# Reading Quality in Three Different Patient Groups

> **NCT03751241** · NA · UNKNOWN · sponsor: **Prim. Prof. Dr. Oliver Findl, MBA** · enrollment: 45 (estimated)

## Conditions studied

- Pseudophakia

## Interventions

- **DEVICE:** EyeTracker

## Key facts

- **NCT ID:** NCT03751241
- **Lead sponsor:** Prim. Prof. Dr. Oliver Findl, MBA
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2019-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03751241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03751241, "Reading Quality in Three Different Patient Groups". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03751241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*